EFFICACY AND SAFETY OF NEMTABRUTINIB VERSUS CHEMOIMMUNOTHERAPY IN PATIENTS WITH PREVIOUSLY UNTREATED CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA WITHOUT TUMOR PROTEIN 53 ABERRATIONS: THE OPEN-LABEL, RANDOMIZED, PHASE 3 BELLWAVE-008 STUDY
- Resource Type
- Abstract
- Source
- In
Hematology, Transfusion and Cell Therapy October 2023 45 Supplement 4:S157-S157 - Subject
- Language
- ISSN
- 2531-1379